Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(21 sites)
China
Anhui Provincial Hospital, Hefei, Anhui The Second Hospital of Anhui Medical University, Hefei, Anhui Beijing Chaoyang Hospital, Capital Medical University, Beijing, Beijing Municipality Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou, Guangdong Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou The first affiliated hospital of Zhengzhou University, Zhengzhou, He'nan The 2nd Affiliated Hospital of Harbin Medical University, Ha’erbin, Helongjiang Wuhan Aier Eye Hospital, Wuhan, Hubei Xiangyang Central Hospital, Xiangyang, Hubei The second norman bethune hospital of Jilin University, Changchun, Jilin Dalian No.3 Peple's Hospital, Dali, Liaoning The 4TH People's Hospital of Shenyang, Shenyang, Liaoning Shandong Eye Hospital, Jinan, Shandong Eye & Ent Hospital of Fudan University, Shanghai, Shanghai Municipality Shanxi Eye Hospital, Taiyuan, Shanxi Panzhihua Hospital of Integrated Chinese and Western Medicine, Panzhihua, Sichuan Tianjin Eye Hospital, Tianjin, Tianjin Municipality Tianjin Medical University Eye Hospital, Tianjin, Tianjin Municipality Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine, Hangzhou, Zhejiang The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Eye Hospital, Wenzhou Medical University / Zhejiang Eye Hospital, Wenzhou, Zhejiang